Hot Blue Chip Stocks To Buy For 2022

tags:GAIN,VALE,INVA,TRVG,

Zacks Investment Research cut shares of Trillium Therapeutics (NASDAQ:TRIL) (TSE:TR) from a buy rating to a hold rating in a research note published on Saturday morning.

According to Zacks, “Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s lead program, SIRPaFc (TTI-621), is a fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory (do not eat) signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic (eat) signals. A Phase 1 clinical trial (NCT02663518) evaluating SIRPaFc is ongoing. Trillium also has a proprietary medicinal chemistry platform, using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties. “

Hot Blue Chip Stocks To Buy For 2022: Gladstone Investment Corporation(GAIN)

We were incorporated under the General Corporation Law of the State of Delaware on February 18, 2005. On June 22, 2005, we completed our initial public offering and commenced operations. We operate as an externally managed, closed-end, non-diversified management investment company and have elected to be treated as a business development company ("BDC") under the Investment Company Act of 1940, as amended (the "1940 Act"). For federal income tax purposes, we have elected to be treated as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "Code"). To continue to qualify as a RIC for federal income tax purposes and obtain favorable RIC tax treatment, we must meet certain requirements, including certain minimum distribution requirements. Since our initial public offering in 2005 and through March 31, 2016, we have made 129 consecutive monthly distributions to common stockholders.   Advisors' Opinion:

• [By Motley Fool Transcribers]

  Gladstone Investment Corp  (NASDAQ:GAIN)Q3 2019 Earnings Conference CallFeb. 06, 2019, 8:30 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator

• [By Stephan Byrd]

  Get a free copy of the Zacks research report on Gladstone Investment (GAIN)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Blue Chip Stocks To Buy For 2022: VALE S.A.(VALE)

We are the second-largest metals and mining company in the world and the largest in the Americas, based on market capitalization. We are the world's largest producer of iron ore and iron ore pellets and the world's second-largest producer of nickel. We are one of the world's largest producers of manganese ore, ferroalloys and kaolin. We also produce bauxite, alumina, aluminum, copper, coal, cobalt, precious metals, potash and other products. To support our growth strategy, we are actively engaged in mineral exploration efforts in 22 countries around the globe. We operate large logistics systems in Brazil, including railroads, maritime terminals and a port, which are integrated with our mining operations. Directly and through affiliates and joint ventures, we have investments in the energy and steel businesses.   Advisors' Opinion:

• [By ]

  As for the companies themselves, familiar names in the top 10 include Walmart's (WMT) Mexican and Central American division Walmart De Mexico, Brazilian miner Vale (VALE) and energy stock Petróleo Brasileiro (PBR). The top 10 holdings account for 55.5% of its $1.5 billion in net assets.

• [By ]

  At times, that philosophy is correct. But it's often better to wait for the impact of the bad news to become clear before buying. That approach explains why I recently told my Profit Amplifier readers that my indicator tools have a "buy" signal on mining giant Vale S. A. (NYSE: VALE). 

• [By Dan Caplinger]

  Companies often have to make key decisions in the face of competitive pressures, and investors can't always quickly tell which moves will prove best. For the marijuana industry, one company's trash was another's treasure, while with Brazilian mining giant Vale (NYSE:VALE), a key executive move showed just how seriously the company is taking a recent disaster.

Hot Blue Chip Stocks To Buy For 2022: Innoviva, Inc. (INVA)

Innoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. Its portfolio focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol (FF/VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). It operates in providing capital return to stockholders by maximizing the potential value of its respiratory assets partnered with GSK segment. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of VI, a LABA and FF, an inhaled corticosteroid (FF/VI) delivered via the ELLIPTA dry powder inhaler. ANORO ELLIPTA is a dual bronchodilator consisting of UMEC, a long-acting muscarinic antagonist (LAMA) and VI, a LABA for the treatment of chronic obstructive pulmonary diseases (COPD). Advisors' Opinion:

• [By Max Byerly]

  Virginia Retirement Systems ET AL lifted its holdings in shares of Innoviva Inc (NASDAQ:INVA) by 67.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 145,100 shares of the biotechnology company’s stock after acquiring an additional 58,700 shares during the period. Virginia Retirement Systems ET AL’s holdings in Innoviva were worth $2,002,000 at the end of the most recent reporting period.

• [By Sean Williams]

  After running a screen for healthcare stocks with a PEG ratio below 1 (courtesy of Yahoo! Finance), the following 13 were all that remained:

  Innoviva (NASDAQ:INVA): 0.42 PEG ratio Celgene (NASDAQ:CELG): 0.54 Mallinckrodt (NYSE:MNK): 0.59 Exelixis (NASDAQ:EXEL): 0.60 Global Cord Blood Corp.: 0.72 AbbVie: 0.75 Vertex Pharmaceuticals: 0.80 DaVita: 0.80 Supernus Pharmaceuticals: 0.80 Mednax: 0.82 MiMedx Group: 0.88 CIGNA: 0.93 Medpace Holdings: 0.95

  Image source: Getty Images.

Hot Blue Chip Stocks To Buy For 2022: trivago N.V. (TRVG)

Trivago NV is a company based in the Netherlands that operates an online hotel search platform. The platform allows users to search for, compare and book hotels. It gathers information from various third parties' platforms and provides information about the hotel, pictures, ratings, reviews and filters, such as price, location and extra options. The Company offers access to approximately 1.3 million hotels in over 190 countries via more than 50 localized websites and applications in various languages. The Company also offers marketing tools and services to hotels and hotel chains, as well as to online travel agencies and advertisers, among others. Its principal executive offices are located in Germany. Advisors' Opinion:

• [By Muslim Farooque]

  However, in the long run, this business model should show resilience. The shortages should be sorted, new car prices will rise and sellers should return as consignment partners.

  Penny Stocks to Buy: Trivago (TRVG) Source: Tobias Arhelger / Shutterstock.com

  Last up on this list of penny stocks is Trivago. A hotel booking platform, Trivago suffered along with the rest of the travel sector due to the Covid-19 pandemic. This is evidenced in its earnings results from the first quarter of 2020 to 2021, where revenues tanked in a big way. However, in its most recent quarter, revenues rose to 95.5 million euros ($112 million), growing by 493% YOY. Therefore, TRVG stock appears to be back in business and should do well as the pandemic eases.

• [By Jeremy Bowman]

  Shares of Trivago (NASDAQ:TRVG) were slipping last month after the hotel meta-search site delivered an underwhelming fourth-quarter earnings report and seemed to get pressured by weak guidance from rival Booking Holdings (NASDAQ: BKNG), as well as broader concerns about the industry.

• [By Motley Fool Transcribing]

  Trivago (NASDAQ:TRVG) Q4 2018 Earnings Conference CallFeb. 6, 2019 8:00 a.m. ET

  Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

  Operator